Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia

NCT01710631 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

791

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Insomnia

Interventions

DRUG: eszopiclone 3 mg
DRUG: placebo

Sponsor

Sumitomo Pharma America, Inc.